Press releases

Boston Scientific applies to FDA for expanded indications for TAXUS Express and TAXUS® Liberte® Stents in AMI patients

Analysis of the data presented at the American College of Cardiology Annual Scientific Sessions

Manufacturing process changes were not submitted for FDA approval; no indication that changes pose any risk to patient safety

First and only premounted, balloon-expandable stent approved specifically for use in iliac arteries

Clinical data presentations to include 12-month results for third-generation TAXUS® Element™ drug-eluting stent